Latest Insider Transactions at Amarin Corp Plcuk (AMRN)
This section provides a real-time view of insider transactions for Amarin Corp Plcuk (AMRN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AMARIN CORP PLCUK to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AMARIN CORP PLCUK's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 30
2021
|
Steven B Ketchum Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,128
-0.7%
|
$15,640
$5.24 P/Share
|
|
Apr 30
2021
|
Steven B Ketchum Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,112
+0.46%
|
-
|
|
Apr 30
2021
|
Michael Wayne Kalb SVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,995
-1.53%
|
$14,975
$5.24 P/Share
|
|
Apr 30
2021
|
Michael Wayne Kalb SVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,112
+1.04%
|
-
|
|
Apr 30
2021
|
Aaron Berg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,817
-2.54%
|
$79,085
$5.17 P/Share
|
|
Apr 30
2021
|
Aaron Berg President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
32,112
+2.42%
|
-
|
|
Mar 31
2021
|
John F Thero President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,604
-0.33%
|
$63,624
$6.37 P/Share
|
|
Mar 31
2021
|
John F Thero President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
26,944
+0.28%
|
-
|
|
Mar 31
2021
|
Joseph T Kennedy General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,803
-1.23%
|
$22,818
$6.37 P/Share
|
|
Mar 31
2021
|
Joseph T Kennedy General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
7,220
+0.78%
|
-
|
|
Mar 31
2021
|
Steven B Ketchum Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,128
-0.71%
|
$18,768
$6.37 P/Share
|
|
Mar 31
2021
|
Steven B Ketchum Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,112
+0.46%
|
-
|
|
Mar 31
2021
|
Michael Wayne Kalb SVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,995
-1.55%
|
$17,970
$6.37 P/Share
|
|
Mar 31
2021
|
Michael Wayne Kalb SVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,112
+1.05%
|
-
|
|
Mar 31
2021
|
Aaron Berg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,012
-1.04%
|
$18,072
$6.37 P/Share
|
|
Mar 31
2021
|
Aaron Berg President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,112
+0.7%
|
-
|
|
Feb 26
2021
|
John F Thero President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
33,965
-0.53%
|
$203,790
$6.74 P/Share
|
|
Feb 26
2021
|
John F Thero President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
86,311
+0.67%
|
-
|
|
Feb 26
2021
|
Joseph T Kennedy General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
12,404
-2.03%
|
$74,424
$6.74 P/Share
|
|
Feb 26
2021
|
Joseph T Kennedy General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
23,558
+1.86%
|
-
|
|
Feb 26
2021
|
Steven B Ketchum Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,483
-1.3%
|
$68,898
$6.74 P/Share
|
|
Feb 26
2021
|
Steven B Ketchum Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,446
+1.24%
|
-
|
|
Feb 26
2021
|
Michael Wayne Kalb SVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,055
-2.89%
|
$66,330
$6.74 P/Share
|
|
Feb 26
2021
|
Michael Wayne Kalb SVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,446
+2.77%
|
-
|
|
Feb 26
2021
|
Aaron Berg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,057
-1.92%
|
$66,342
$6.74 P/Share
|
|
Feb 26
2021
|
Aaron Berg President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,446
+1.88%
|
-
|
|
Feb 25
2021
|
John F Thero President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
153,739
-4.7%
|
$1,076,173
$7.3 P/Share
|
|
Feb 25
2021
|
John F Thero President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
390,696
+10.67%
|
-
|
|
Feb 25
2021
|
Joseph T Kennedy General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
55,140
-15.99%
|
$385,980
$7.3 P/Share
|
|
Feb 25
2021
|
Joseph T Kennedy General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
104,728
+23.3%
|
-
|
|
Feb 25
2021
|
Steven B Ketchum Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
45,327
-9.61%
|
$317,289
$7.3 P/Share
|
|
Feb 25
2021
|
Steven B Ketchum Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
88,614
+15.82%
|
-
|
|
Feb 25
2021
|
Michael Wayne Kalb SVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
43,395
-19.82%
|
$303,765
$7.3 P/Share
|
|
Feb 25
2021
|
Michael Wayne Kalb SVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
88,614
+28.81%
|
-
|
|
Feb 25
2021
|
Aaron Berg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
43,638
-13.82%
|
$305,466
$7.3 P/Share
|
|
Feb 25
2021
|
Aaron Berg President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
88,614
+21.92%
|
-
|
|
Feb 01
2021
|
Steven B Ketchum Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
217,728
-19.12%
|
$1,741,824
$8.05 P/Share
|
|
Feb 01
2021
|
Steven B Ketchum Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
192,358
+9.14%
|
$384,716
$2.65 P/Share
|
|
Jan 29
2021
|
John F Thero President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
82,762
-1.4%
|
$579,334
$7.5 P/Share
|
|
Jan 29
2021
|
John F Thero President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
209,171
+1.74%
|
-
|
|
Jan 29
2021
|
Joseph T Kennedy General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
16,711
-3.31%
|
$116,977
$7.5 P/Share
|
|
Jan 29
2021
|
Joseph T Kennedy General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
42,345
+4.01%
|
-
|
|
Jan 29
2021
|
Michael Wayne Kalb SVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,928
-5.28%
|
$104,496
$7.5 P/Share
|
|
Jan 29
2021
|
Michael Wayne Kalb SVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
41,789
+6.81%
|
-
|
|
Jan 29
2021
|
Aaron Berg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,281
-1.37%
|
$43,967
$7.5 P/Share
|
|
Jan 29
2021
|
Aaron Berg President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,789
+2.19%
|
-
|
|
Jan 29
2021
|
Steven B Ketchum Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
21,535
-2.53%
|
$150,745
$7.5 P/Share
|
|
Jan 29
2021
|
Steven B Ketchum Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,789
+2.39%
|
-
|
|
Jan 27
2021
|
Steven B Ketchum Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
421,629
-30.67%
|
$3,373,032
$8.01 P/Share
|
|
Jan 27
2021
|
Steven B Ketchum Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
278,237
+4.75%
|
$556,474
$2.4 P/Share
|